Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Facharztpraxis für Nierenheilkunde

Research site

Germany Burgstraße 5, 27356 Rotenburg, Germany

  • 1 trial recruiting
  • Chronic kidney disease
  • Adult patients

About Specializations

Facharztpraxis für Nierenheilkunde in Rotenburg, Germany specialises in clinical trials of conditions such as Chronic kidney disease, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

The research at this site centers on cardiovascular diseases as they relate to chronic kidney health, aiming to improve treatment outcomes for adults with CKD and renal insufficiency.

  • Evaluating novel agents to slow CKD progression
  • Assessing cardiovascular risk reduction in kidney disease
  • Testing combination therapies with SGLT2 inhibitors
  • Investigating endpoints of eGFR decline and kidney failure

Researchers at Facharztpraxis für Nierenheilkunde are dedicated to generating evidence that can guide clinical practice for patients with chronic kidney disease, independent of diabetes status.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Burgstraße 527356 RotenburgGermany
Open in maps ↗
Recruiting now
1 trial
Conditions studied
1

More sites in RotenburgGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Chronic kidney disease

Recruiting

Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Chronic kidney disease

Not yet recruiting

Phase III Randomized Study of Balcinrenone and Dapagliflozin Versus Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Chronic Kidney Disease Stage 3b‑4

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.